Kozak & Associates’s GE HealthCare GEHC Stock Holding History

Kozak & Associates’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.67K	Sell	57 -2	-3%	-$131	﹤0.01%	333
2026 Q1	$4.33K	Sell	59 -18	-23%	-$1.42K	﹤0.01%	325
2025 Q4	$6.69K	Hold	77	–	–	﹤0.01%	284
2025 Q3	$5.41K	Hold	77	–	–	﹤0.01%	303
2025 Q2	$5.79K	Hold	77	–	–	﹤0.01%	282
2025 Q1	$4.94K	Sell	77 -59	-43%	-$5.07K	﹤0.01%	293
2024 Q4	$10.9K	Sell	136 -595	-81%	-$50.6K	﹤0.01%	231
2024 Q3	$66K	Hold	731	–	–	0.02%	120
2024 Q2	$56.5K	Sell	731 -179	-20%	-$14.6K	0.01%	122
2024 Q1	$74K	Sell	910 -184	-17%	-$15.3K	0.02%	111
2023 Q4	$82K	Sell	1,094 -77	-7%	-$5.39K	0.03%	115
2023 Q3	$80.2K	Sell	1,171 -26	-2%	-$1.89K	0.03%	112
2023 Q2	$96.6K	Hold	1,197	–	–	0.04%	108
2023 Q1	$98.2K	Buy	+1,197	New	+$85.5K	0.04%	114

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Kozak & Associates's GEHC Position: Q2 2026 in Review

Kozak & Associates reduced its GE HealthCare (GEHC) stake by 3.4% in Q2 2026, selling an estimated $131 and leaving 57 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

Kozak & Associates first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $98.2K in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Kozak & Associates held 57 shares of GE HealthCare worth $3.67K as of Q2 2026.
Kozak & Associates sold 2 GE HealthCare shares in Q2 2026, an estimated $131.
GE HealthCare made up ﹤0.01% of Kozak & Associates's portfolio in Q2 2026, its #333 holding.
Kozak & Associates first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
Kozak & Associates's GE HealthCare position peaked at $98.2K in Q1 2023.
1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.